PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Weight loss drug helps curb cocaine addictions, Penn study finds

Addicts on topiramate were more likely to stay in treatment and use less cocaine, but not alcohol

2013-07-19
(Press-News.org) PHILADELPHIA—The drug topiramate, typically used to treat epilepsy and more recently weight loss, may also help people addicted to both cocaine and alcohol use less cocaine, particularly heavy users, researchers in the department of Psychiatry at Penn Medicine report in a new study published in Drug and Alcohol Dependence. Results from the double-blind, placebo-controlled trial adds to the growing body of evidence supporting topiramate as a promising medication to treat addiction.

Past, separate studies have shown that topiramate can reduce alcohol dependence, as well as reduce relapse to cocaine; however, its use to treat both alcohol and cocaine dependent people has not been explored in a clinical trial. Cocaine and alcohol addictions often go hand in hand, so therapies targeting both may be the best strategy to treat individuals.

Results of the 13-week clinical trial of 170 alcohol and cocaine dependent people produced mixed results: The drug reduced alcohol cravings, but did not reduce drinking, and was not better at reducing cocaine cravings. Addicts on topiramate, however, versus those on a placebo were more likely to stay in treatment and abstain from cocaine during the last three weeks of the trial. People with more severe cocaine withdrawal symptoms— agitation, restless behavior, and depressed mood—appeared to have benefited most from topiramate.

"Cocaine dependence continues to be a significant public health concern in the United States and Europe. Drug counseling remains the treatment of choice, but many patients do not respond completely to it, so developing effective medications for treatment is a research priority," said first author Kyle M. Kampman, MD, professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania, and medical director at the Charles O'Brien Center for Addiction Treatment. "Based on the study's results, this drug, plus cognitive behavioral therapy, may be a good option for people addicted to both alcohol and cocaine to help reduce their cocaine use."

Topiramate is an anticonvulsant drug that increases the brain levels of GABA, or gamma-Aminobutyric acid, which is a primary inhibitory neurotransmitter in the central nervous system. It is FDA approved for the treatment of epilepsy, migraines and more recently for weight loss in combination with phentermine.

For drug and alcohol addiction, it is thought that the increase of GABA may reduce the dopamine release associated with cocaine and alcohol use and thus reduce the reinforcing euphoric effects of the two. A small pilot study in 2005 by Dr. Kampman and colleagues found that topiramate helped cocaine addicts stay off the drug for three weeks or more.

Given prior studies, it's puzzling that topiramate did not reduce alcohol dependence, but could be explained by the severity of the group's addiction to it, the authors write. The percent days of heavy drinking for participants in this trial were much lower than past studies (12 percent vs 48 percent in some cases). Topiramate may have a greater effect in those who drink more heavily.

The double-blind, placebo-controlled trial included addicts whose average age was 45 and were mainly African American males who smoked crack cocaine. There was no significant difference, with respect to demographics, drug and alcohol use and amount of money spent on substances, between the two groups. Drug and alcohol tests were performed three times a week.

During the last three weeks of the trial, 20 percent of users on topiramate abstained from cocaine, compared to just 7 percent on the placebo. Heavy users also had significantly more negative cocaine drug tests during the trial compared to placebo-treated subjects (17.6 percent vs. 8.8 percent.) The drug likely had a more positive impact on heavy user users because they experience higher levels of cocaine euphoria, said Dr. Kampman.

Sixty-five percent of participants on topiramate stayed in the trial, while 59 percent of subjects on the placebo stayed—a statistically significant difference.

"This study further supports topiramate as a promising medication for people who are both alcohol and cocaine dependent," said Dr. Kampman. "Future studies are planned in which topiramate will be combined with other promising medications for the treatment of cocaine dependence in the hope of achieving even higher levels of cocaine abstinence than were achieved with topiramate alone."

INFORMATION:

Co-authors of the study include Helen M. Pettinati, PhD, department of Psychiatry, Kevin G. Lynch, PhD, department of Psychiatry and the Center for Clinical Epidemiology and Biostatistics (CCEB), Kelly Spratt, DO, department of Medicine, Michael R. Wierzbicki, of CCEB, and Charles P. O'Brien, of the department of Psychiatry.

END



ELSE PRESS RELEASES FROM THIS DATE:

Study analyzes dynamical properties in antibiotic resistance enzyme

2013-07-19
Antibiotic-resistant bacteria have been emerging at an alarming rate. In some of the scariest of these pathogens, the mechanism responsible for the bacteria's ability to defeat antibiotics is a complex protein molecule embedded in the bacterial cell wall -- the enzyme β-lactamase. The rapid evolution of β-lactamase is the key factor responsible for the growing antibiotic resistance of some of the most terrifying pathogenic bacteria on the planet – bacteria which are becoming rapidly immune to most, if not all, of our drugs. We can trace the genetic changes ...

Snow in an infant solar system

2013-07-19
Astronomers using the Atacama Large Millimeter/submillimeter Array (ALMA - http://www.eso.org/alma) have taken the first ever image of the snow line in an infant solar system. On Earth, snow lines form at high altitudes where falling temperatures turn the moisture in the air into snow. This line is clearly visible on a mountain, where the snow-capped summit ends and the rocky face begins. The snow lines around young stars form in a similar way, in the distant, colder reaches of the dusty discs from which solar systems form. Starting from the star and moving outwards, ...

How Mars' atmosphere got so thin: New insights from Curiosity

2013-07-19
ANN ARBOR—New findings from NASA's Curiosity rover provide clues to how Mars lost its original atmosphere, which scientists believe was much thicker than the one left today. "The beauty of these measurements lies in the fact that these are the first really high-precision measurements of the composition of Mars' atmosphere," said Sushil Atreya, professor of atmospheric, oceanic and space sciences at the University of Michigan. Atreya is co-author of two related papers published in the July 19 issue of Science, and co-investigator on Curiosity's Sample Analysis at Mars ...

A snow line in an infant solar system: Astronomers take first images

2013-07-19
ANN ARBOR—Like the elevation in the Rocky Mountains where the snow caps begin, a snow line in a solar system is the point where falling temperatures freeze and clump together water or other chemical compounds that would otherwise be vapor. Astronomers believe snow lines in space serve a vital role in forming planets because frozen moisture can help dust grains stick together. Astronomers have, for the first time, directly imaged a snow line at another star. Using the new Atacama Larger Millimeter/submillimeter Array (ALMA) telescope in Chile, they obtained radio-wavelength ...

New research suggests that gingival stem cells can be used in tissue regeneration

2013-07-19
Alexandria, Va., USA – Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "Gingivae Contain Neural-crest- and Mesoderm-derived Mesenchymal Stem Cells." The paper, written by lead author Songtao Shi, Center for Craniofacial Molecular Biology, Ostrow School of Dentistry, University of Southern California, Los Angeles, USA, is published in the OnlineFirst portion of the IADR/AADR Journal of Dental Research. Gingivae represent a unique soft tissue that serves as a biological barrier to cover the oral cavity side of ...

Good vibrations: Mediating mood through brain ultrasound

2013-07-19
University of Arizona researchers have found in a recent study that ultrasound waves applied to specific areas of the brain appear able to alter patients' moods. The discovery has led the scientists to conduct further investigations with the hope that this technique could one day be used to treat conditions such as depression and anxiety. Dr. Stuart Hameroff, professor emeritus of the UA's departments of anesthesiology and psychology and director of the UA's Center for Consciousness Studies, is lead author on the first clinical study of brain ultrasound, which was published ...

Facebook for molecules

2013-07-19
Social media has expanded to reach an unlikely new target: molecules. Scientists at the National Institute of Standards and Technology (NIST) have created networks of molecular data similar to Facebook's recently debuted graph search feature. While graph search would allow Facebook users to find all their New York-living, beer-drinking buddies in one quick search, the NIST-designed networks could help scientists rapidly sift through enormous chemical and biological data sets to find substances with specific properties, for example all 5-ring chemicals with an affinity for ...

A secret to making macrophages

2013-07-19
VIDEO: This is a iime-lapse movie of blood progenitor cells dividing and differentiating in culture. The brightness of green fluorescence indicates the amount of the regulatory protein PU.1 present in each... Click here for more information. Biologists at the California Institute of Technology (Caltech) have worked out the details of a mechanism that leads undifferentiated blood stem cells to become macrophages—immune cells that attack bacteria and other foreign pathogens. ...

HIV/AIDS vaccines: Defining what works

2013-07-19
Designing an effective HIV/AIDS vaccine is something of a paradox: a good vaccine would be safe and look enough like HIV to kick-start the immune system into neutralizing the virus – but the problem is that this is exactly what the human immune system has trouble doing even when it's exposed to the real thing. Now a team of researchers led by scientists at The Scripps Research Institute in La Jolla, Calif. has developed a strategy for inducing a key part of an effective immune response to HIV. By tracing the evolution of HIV-recognizing molecules called antibodies taken ...

Unusual material expands dramatically under pressure

2013-07-19
If you squeeze a normal object in all directions, it shrinks in all directions. But a few strange materials will actually grow in one dimension when compressed. A team of chemists has now discovered a structure that takes this property to a new level, expanding more dramatically under pressure than any other known material. The finding could lead to new kinds of pressure sensors and artificial muscles. Andrew Cairns, a graduate student at the University of Oxford and a member of the research team, will discuss the new material and its applications at the American Crystallographic ...

LAST 30 PRESS RELEASES:

Revised diagnostic criteria for vascular cognitive impairment and dementia—The VasCog-2-WSO criteria

The ATREIDES program in search of lost exo-Neptunes

Ancient crop discovered in the Canary Islands thanks to archaeological DNA

Placental research may transform our understanding of autism and human brain evolution

Mapping the Universe, faster and with the same accuracy

Study isolates population aging as primary driver of musculoskeletal disorders

Designing a sulfur vacancy redox disruptor for photothermoelectric and cascade‑catalytic‑driven cuproptosis–ferroptosis–apoptosis therapy

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

Construction secrets of honeybees: Study reveals how bees build hives in tricky spots

Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021

New funding fuels development of first potentially regenerative treatment for multiple sclerosis

NJIT student–faculty team wins best presentation award for ant swarm simulation

Ants defend plants from herbivores but can hinder pollination

When the wireless data runs dry

Inquiry into the history of science shows an early “inherence” bias

Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores

Study suggests most Americans would be healthier without daylight saving time

[Press-News.org] Weight loss drug helps curb cocaine addictions, Penn study finds
Addicts on topiramate were more likely to stay in treatment and use less cocaine, but not alcohol